These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24671665)

  • 1. [Hypoglycemia and cardiac arrhythmia in patients with diabetes mellitus type 2].
    Hanefeld M; Ganz X; Nolte C
    Herz; 2014 May; 39(3):312-9. PubMed ID: 24671665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study.
    Andersen A; Bagger JI; Sørensen SK; Baldassarre MPA; Pedersen-Bjergaard U; Forman JL; Gislason G; Lindhardt TB; Knop FK; Vilsbøll T
    Cardiovasc Diabetol; 2021 Dec; 20(1):241. PubMed ID: 34952579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions.
    Pistrosch F; Ganz X; Bornstein SR; Birkenfeld AL; Henkel E; Hanefeld M
    Acta Diabetol; 2015 Oct; 52(5):889-95. PubMed ID: 25749806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality for Widely Used Antihyperglycemic Dual and Triple Therapies for Type 2 Diabetes Management: A Cohort Study of All Danish Users.
    Jensen MH; Kjolby M; Hejlesen O; Jakobsen PE; Vestergaard P
    Diabetes Care; 2020 Jun; 43(6):1209-1218. PubMed ID: 32238426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk.
    Chow E; Bernjak A; Williams S; Fawdry RA; Hibbert S; Freeman J; Sheridan PJ; Heller SR
    Diabetes; 2014 May; 63(5):1738-47. PubMed ID: 24757202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SODIUM GLUCOSE COTRANSPORTER 2 AND DIPEPTIDYL PEPTIDASE-4 INHIBITION: PROMISE OF A DYNAMIC DUO.
    Lingvay I
    Endocr Pract; 2017 Jul; 23(7):831-840. PubMed ID: 28332871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
    Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
    Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Effects of Sulfonylurea-Related Hypoglycemia.
    Middleton TL; Wong J; Molyneaux L; Brooks BA; Yue DK; Twigg SM; Wu T
    Diabetes Care; 2017 May; 40(5):663-670. PubMed ID: 28223296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant abnormal glycemic variability increased the risk for arrhythmias in elderly type 2 diabetic patients.
    Zhang J; Yang J; Liu L; Li L; Cui J; Wu S; Tang K
    BMC Endocr Disord; 2021 Apr; 21(1):83. PubMed ID: 33906667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hypoglycemia in older adults with type 2 diabetes.
    Freeman J
    Postgrad Med; 2019 May; 131(4):241-250. PubMed ID: 30724638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypoglycemia could increase the risk of arrhythmia in diabetics, explaining the increased cardiovascular mortality in the intensive control of blood glucose].
    Chanson P; Pariente A
    Rev Prat; 2014 May; 64(5):614. PubMed ID: 24923040
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.
    Korzon-Burakowska A; Hopkins D; Matyka K; Lomas J; Pernet A; Macdonald I; Amiel S
    Diabetes Care; 1998 Feb; 21(2):283-90. PubMed ID: 9539997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes: A randomized, placebo-controlled study.
    Farngren J; Persson M; Ahrén B
    Diabetes Obes Metab; 2018 Aug; 20(8):1911-1920. PubMed ID: 29645341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    Sci Rep; 2021 Jan; 11(1):137. PubMed ID: 33420333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia.
    Nyström T; Bodegard J; Nathanson D; Thuresson M; Norhammar A; Eriksson JW
    Diabetes Res Clin Pract; 2017 Jan; 123():199-208. PubMed ID: 28056431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network meta-analysis of treatments for type 2 diabetes mellitus following failure with metformin plus sulfonylurea.
    Lozano-Ortega G; Goring S; Bennett HA; Bergenheim K; Sternhufvud C; Mukherjee J
    Curr Med Res Opin; 2016 May; 32(5):807-16. PubMed ID: 26700585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus.
    Barnett AH; Charbonnel B; Moses RG; Kalra S
    Curr Med Res Opin; 2015; 31(10):1919-31. PubMed ID: 26361231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.
    Thein D; Christiansen MN; Mogensen UM; Bundgaard JS; Rørth R; Madelaire C; Fosbøl EL; Schou M; Torp-Pedersen C; Gislason G; Køber L; Kristensen SL
    Cardiovasc Diabetol; 2020 Jul; 19(1):107. PubMed ID: 32631337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes.
    Yun JS; Ko SH
    Korean J Intern Med; 2015 Jan; 30(1):6-16. PubMed ID: 25589828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.